Who invested in Hexigone Inhibitors?
Hexigone Inhibitors's investors include ACF Investors, Development Bank of Wales and UK government.

United Kingdom · Seed startup
Funding summaryUpdated 26 Oct 2026
$5.3Mraised across 7 rounds since 2022, from 7 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Hexigone Inhibitors's investors include ACF Investors, Development Bank of Wales and UK government.
Hexigone Inhibitors has raised $5.3M across 7 rounds since 2022.
Hexigone Inhibitors's most recent round was a Seed of $1.6M in Jun 2026.
Its most recent round, $1.6M in Jun 2026, is also its largest on record.
Hexigone Inhibitors's first round on record, in Sept 2024, was backed by ACF Investors and Development Bank of Wales.
Hexigone Inhibitors's latest named round is a Seed, in Jun 2026.
Hexigone Inhibitors is based in the United Kingdom.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.